Matthew Harinstein, MD, FACC, FASE, FASNC, reviews the latest updates on cardio-oncology guidelines and identifies patients at increased risk for cancer therapeutics related to cardiac dysfunction (CTRCD). Dr. Harinstein also presents preventive, surveillance, and management strategies to minimize risk and provide treatment.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify risk factors for cancer-related cardiomyopathy
- Explain surveillance of chemotherapy
- Describe use of strain imaging in cardio-oncology
Disclosures
Dr. Harinstein has reported no relevant relationships with entities producing health care goods or services.
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of .50 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page..
Release Date: 2/26/2020 | Last Modified On: 2/26/2020 | Expires: 2/26/2021
